GARDASIL
žGARDASIL is the only cervical cancer vaccine that helps protect against ONLY 4 of approx. 100 types of HPV
›2 types that cause 70% of cervical cancer cases (Types 16 & 18)
›2 more types that cause 90% of genital warts cases. (Types 6 & 11)
ž GARDASIL is for girls and young women ages 9 to 26.
ž GARDASIL was approved by the Food and Drug Administration (FDA) for use in boys and young men ages 9 to 26 to help protect against 90% of genital warts cases.
›Since Gardasil was publicized, it is becoming more commonly discussed in sex ed
žGARDASIL may not fully protect everyone, and DOES NOT prevent all types of cervical cancer
žIt’s important to continue routine cervical cancer screenings.
žGARDASIL does not treat cervical cancer or genital warts.
žGARDASIL will not protect against diseases caused by other HPV types or against diseases not caused by HPV.
žGARDASIL is given as 3 injections over 6 months
žGET PROTECTED!!!!
›2 types that cause 70% of cervical cancer cases (Types 16 & 18)
›2 more types that cause 90% of genital warts cases. (Types 6 & 11)
ž GARDASIL is for girls and young women ages 9 to 26.
ž GARDASIL was approved by the Food and Drug Administration (FDA) for use in boys and young men ages 9 to 26 to help protect against 90% of genital warts cases.
›Since Gardasil was publicized, it is becoming more commonly discussed in sex ed
žGARDASIL may not fully protect everyone, and DOES NOT prevent all types of cervical cancer
žIt’s important to continue routine cervical cancer screenings.
žGARDASIL does not treat cervical cancer or genital warts.
žGARDASIL will not protect against diseases caused by other HPV types or against diseases not caused by HPV.
žGARDASIL is given as 3 injections over 6 months
žGET PROTECTED!!!!
CERVARIX
CERVARIX is a vaccine indicated for the prevention of the following diseases caused by oncogenic human papillomavirus (HPV) types 16 and 18:
Limitations of Use and Effectiveness
- cervical cancer
- cervical intraepithelial neoplasia (CIN) grade 2 or worse and adenocarcinomain situ (AIS)
- cervical intraepithelial neoplasia (CIN) grade 1
- CERVARIX is approved for use in females 10 through 25 years of age.
Limitations of Use and Effectiveness
- CERVARIX does not provide protection against disease due to all HPV types
- CERVARIX has not been demonstrated to provide protection against disease from vaccine and non-vaccine HPV types to which a woman has previously been exposed through sexual activity
- Females should continue to adhere to recommended cervical cancer screening procedures
- Vaccination with CERVARIX may not result in protection in all vaccine recipients
Compared
How are the two HPV vaccines similar?
- Both vaccines are very effective against HPV types 16 and 18, which cause most cervical cancers. So both vaccines prevent cervical cancer and precancer in women.
- Both vaccines are very safe.
- Both vaccines are made with very small parts of the human papillomavirus (HPV) that cannot cause infection with HPV, so neither of the vaccines can cause HPV infection.
- Both vaccines are given as shots and require 3 doses.
- Only one of the vaccines (Gardasil) also protects against HPV types 6 and 11. These HPV types cause most genital warts in females and males.
- The vaccines have different adjuvants—a vaccine adjuvant is a substance that is added to the vaccine to increase the body's immune response.
